MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway

Despite improvements in therapies and screening strategies, lung cancer prognosis still remains dismal, especially for metastatic tumors. Cancer stem cells (CSCs) are endowed with properties such as chemoresistance, dissemination, and stem-like features, that make them one of the main causes of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moro, Massimo, Fortunato, Orazio, Bertolini, Giulia, Mensah, Mavis, Borzi, Cristina, Centonze, Giovanni, Andriani, Francesca, Di Paolo, Daniela, Perri, Patrizia, Ponzoni, Mirco, Pastorino, Ugo, Sozzi, Gabriella, Boeri, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951736/
https://www.ncbi.nlm.nih.gov/pubmed/35337095
http://dx.doi.org/10.3390/ph15030297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951736/
https://www.ncbi.nlm.nih.gov/pubmed/35337095
http://dx.doi.org/10.3390/ph15030297

Ejemplares similares